|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
33
|
|
pubmed:dateCreated |
2009-11-20
|
|
pubmed:abstractText |
To reassess traditional ultrasound descriptors of sentinel lymph node (SLN) metastases, to determine the minimum cross-sectional area (CSA) of an SLN metastasis detectable by ultrasound (US), and to establish whether targeted, high-resolution US of SLNs identified by lymphoscintigraphy before initial melanoma surgery can be used as a substitute for excisional SLN biopsy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
20
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
5614-9
|
|
pubmed:meshHeading |
pubmed-meshheading:19786669-Adult,
pubmed-meshheading:19786669-Aged,
pubmed-meshheading:19786669-Biopsy, Fine-Needle,
pubmed-meshheading:19786669-Cohort Studies,
pubmed-meshheading:19786669-Confidence Intervals,
pubmed-meshheading:19786669-Contrast Media,
pubmed-meshheading:19786669-Female,
pubmed-meshheading:19786669-Humans,
pubmed-meshheading:19786669-Lymph Nodes,
pubmed-meshheading:19786669-Lymphatic Metastasis,
pubmed-meshheading:19786669-Male,
pubmed-meshheading:19786669-Melanoma,
pubmed-meshheading:19786669-Middle Aged,
pubmed-meshheading:19786669-Neoplasm Staging,
pubmed-meshheading:19786669-Predictive Value of Tests,
pubmed-meshheading:19786669-Prognosis,
pubmed-meshheading:19786669-Retrospective Studies,
pubmed-meshheading:19786669-Risk Assessment,
pubmed-meshheading:19786669-Sensitivity and Specificity,
pubmed-meshheading:19786669-Sentinel Lymph Node Biopsy,
pubmed-meshheading:19786669-Skin Neoplasms,
pubmed-meshheading:19786669-Ultrasonography, Doppler,
pubmed-meshheading:19786669-Young Adult
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Targeted high-resolution ultrasound is not an effective substitute for sentinel lymph node biopsy in patients with primary cutaneous melanoma.
|
|
pubmed:affiliation |
Melanoma Institute Australia and Sydney Melanoma Unit, Royal Prince Alfred and Mater Hospitals, Sydney, New South Wales, Australia
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
